Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DYRKs-IN-1 has antitumor activity. DYRKs-IN-1 is a potent DYRKs (Dual-specificity tyrosine-phosphorylation-regulated kinases) inhibitor with IC50s of 9 nM and 5 nM for DYRK1B and DYRK1A, respectively.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 10-14 weeks | $ 2,870.00 | |
50 mg | 10-14 weeks | $ 3,780.00 | |
100 mg | 10-14 weeks | $ 5,200.00 |
Description | DYRKs-IN-1 has antitumor activity. DYRKs-IN-1 is a potent DYRKs (Dual-specificity tyrosine-phosphorylation-regulated kinases) inhibitor with IC50s of 9 nM and 5 nM for DYRK1B and DYRK1A, respectively. |
Targets&IC50 | DYRK1B:9 nM , DYRK1A:5 nM |
In vitro | Dyrks-in-1 enhanced the efficacy of human colon cancer cell line SW 620 with EC50 at 27 nM. |
Molecular Weight | 588.06 |
Formula | C30H30ClN7O4 |
CAS No. | 1387090-01-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
DYRKs-IN-1 1387090-01-8 Cell Cycle/Checkpoint Tyrosine Kinase/Adaptors DYRK DYRKsIN1 DYRKs IN 1 inhibitor inhibit